{"slideshow_credits": null, "snippet": "AstraZeneca on Monday rejected Pfizer\u2019s latest \u2014 and, according to the American pharmaceutical giant, its final \u2014 takeover bid. The offer, made Sunday evening, was worth about $119 billion.", "abstract": "AstraZeneca on Monday rejected Pfizer\u2019s latest \u2014 and, according to the American pharmaceutical giant, its final \u2014 takeover bid. The offer, made Sunday evening, was worth about $119 billion.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2014/05/19/astrazeneca-rejects-final-offer-by-pfizer/", "lead_paragraph": null, "headline": {"main": "AstraZeneca Snubs Pfizer Once More ", "print_headline": "AstraZeneca Snubs Pfizer Once More", "kicker": "DealBook"}, "_id": "5379b1a638f0d805525a3486", "word_count": "1234", "multimedia": [{"height": 126, "url": "images/2014/05/20/business/DRUG2/DRUG2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/20/business/DRUG2/DRUG2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 383, "url": "images/2014/05/20/business/DRUG/DRUG-articleLarge.jpg", "legacy": {"xlarge": "images/2014/05/20/business/DRUG/DRUG-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "383"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/20/business/DRUG/DRUG-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/05/20/business/DRUG/DRUG-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-19T03:23:42Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Johansson, Leif", "rank": "1"}, {"name": "organizations", "value": "Pfizer Inc", "rank": "2"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "2"}, {"name": "subject", "value": "Corporate Taxes", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}